Johnson & Johnson (NYSE: JNJ)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Johnson & Johnson Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Johnson & Johnson Company Info
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
News & Analysis
The market is still giving investors great opportunities to buy exceptional companies.
Learn about some of the leading cancer stocks in the U.S stock market this year.
The worst might be in the rearview mirror as far as the latest bear market is concerned.
The growth prospects for these two businesses should improve as they become leaner.
These businesses are performing much better than their stock prices would suggest.
Find out which index funds tracking the S&P 500 have the lowest fees and most closely track the market.
Close to its 52-week low, this healthcare stalwart remains a good purchase.
These healthcare-focused businesses should be able to raise their quarterly payouts for many years to come.
Plus, we run through some shortcuts that could help you with your financial planning.
Plus, a look at the 4% rule and a common misconception about retirement spending.
Plus a look at what to like about Johnson & Johnson.
The latest news in the pharmaceuticals, technology, and social media landscapes.
JNJ earnings call for the period ending December 31, 2022.
JNJ earnings call for the period ending September 30, 2022.
JNJ earnings call for the period ending June 30, 2022.
JNJ earnings call for the period ending March 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.